CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
48
Frequently Asked Questions
What is Market Cap of CAMP4 Therapeutics Corp.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. CAMP4 Therapeutics Corp. market cap is $233.67M.
What is the 52-week high for CAMP4 Therapeutics Corp.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. CAMP4 Therapeutics Corp. 52 week high is $7.75 as of July 14, 2026.
What is the 52-week low for CAMP4 Therapeutics Corp.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CAMP4 Therapeutics Corp. 52 week low is $1.32 as of July 14, 2026.
What is CAMP4 Therapeutics Corp. stock price today?
CAMP4 Therapeutics Corp. stock price today is $4.45.
What was CAMP4 Therapeutics Corp. stock price yesterday?
CAMP4 Therapeutics Corp. stock price yesterday was $4.50.
What is the PE ratio of CAMP4 Therapeutics Corp.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. CAMP4 Therapeutics Corp.'s P/E ratio is -1.98.
What is the Price-to-Book ratio of CAMP4 Therapeutics Corp.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. CAMP4 Therapeutics Corp. P/B ratio is 7.5615.
What is the 50-day moving average of CAMP4 Therapeutics Corp.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. CAMP4 Therapeutics Corp. 50-day moving average is $4.25.
How many employees does CAMP4 Therapeutics Corp. have?
